Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics

Neuropsychopharmacology

Volumn 8, Issue 4, 1993, Pages 315-336

  Joyce, Jefey N ^a   Shane, Andi ^a   Lexow, Nedra ^a   Winokur, Andrew ^a   Casanova, Manuel F ^b   Kleinman, Joel E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cortex; Hippocampus; Quantitative autoradiography; Schizophrenia; Serotonim receptor; SerotonimA receptor; Serotonin uptake; Striatum

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; IMIPRAMINE; KETANSERIN; LYSERGIDE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIMBIC SYSTEM; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; KINETICS; LIMBIC SYSTEM; MALE; MIDDLE AGE; MOTOR CORTEX; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SEROTONIN; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE;

EID: 0027279038     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.1993.32     Document Type: Article

References (78)

1. Amaral DG, Campbell MJ (1986): Transmitter systems in the primate dentate gyrus. Human Neurobiol 5:169-180
2. Amaral DG, Insausti R (1990): Hippocampal formation. In Paxinos G (ed), The Human Nervous System. New York, Academic Press, pp 711-755
3. Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY (1986): Differential effect of subchronic treatment with various neuroleptic agents on serotoni receptors in rat cerebral cortex. J Neurochem 46:191-197
4. Arango V, Ernsberger P, Marzuk PM, Chen H-S, Tierney H, Stanley M, Reis DJ, Mann JJ (1990): Autoradiographic demonstration of increased serotonin 5-HT2 and P-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047
5. Arora RC, Meltzer HY (1989a): Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146:730-736
6. Arora RC, Meltzer N (1989b): 3H-imipramine binding in the frontal cortex of suicides. Psychiatry Res 30:125-135
7. Arora RC, Meltzer HY (1991): Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. Am J Psychiatry 146:730-736
8. Artymyshyn R, Smith A, Wolfe BB (1990): The use of 3h standards in 1251 autoradiography. J Neurosci Method 32:185-192
9. Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979): Neurotransmitter receptor in frontal cortex of schizophrenics. Arch Gen Psychiatry 36:927-934
10. Biegon A, Kargman S, Snyder L, McEwen BS (1986): Characterization and localization of serotonin receptors in human brain postmortem. Brain Res 363:91-98
11. Bleich A, Brown S-L, Kahn R, vanPraag HM (1988): The role of serotonin in schizophrenia. Schizophrenia Bull 14:287-315
12. Castelaoo JF, Ferreira L, Gelder YG, Heylen SL (1989): The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study. Schizophrenia Res 2:411-415
13. 3H]paroxetine. Neuroscience 27:473-496
14. Crow TJ, Baker H, Gross A, Joseph M, Lofthouse R, Long-den A, Owen F, Riley G, Glover V, Killpack W (1979): Monoamine mechanisms in chronic schizophrenia: Postmortem neurochemical findings. B J Psychiatry 134: 249-256
15. Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry H, Tomlinson BE (1984): Neurotransmitter receptors and monoamine metabolites in brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561-1569
16. D'Amato RJ, Largent BL, Snowman Snyder SH (1987): Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to the labeling of multiple sites by pHJimipramine. J Pharmacol Exp Ther 242: 364-371
17. Demeter E, Tekes K, Majorossy K, Palkovits M, Soos M, Magyar K, Somogy E (1989): The asymmetry of 3H-imi-pramine binding may predict psychiatric illness. Life Sci 44:1403-1410
18. De Vivo M, Maayani S (1990): Stimulation and inhibition of adenylyl cyclase by district 5-hydroxytryptamine receptors. Biochem Pharmacol 40:1551-1558
19. Dillon A., Gross-Isseroff R, Israeli M, Biegon A (1991):Autoradiographic analysis of serotonin 5-HTia receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res 554:56-64
20. Engel G, Muller-Schweinitzer E, Palacios JM (1984): [i25Iodo]LSD, a new ligand for the characterisation and localization of 5-HT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 325:328-336
21. Farley I, Shannak K, Hornykiewicz O (1980): Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. In Pepeu G, Kuhar M, Enna S (eds), Receptors for Neurotransmitters and Peptide Hormones. New York, Raven Press, pp 427-433
22. Frazer A, Offord SJ, Lucki I (1988): Regulation of serotonin receptors and responsiveness in the brain. In Sanders-Bush E (ed), The Serotonin Receptors. Clifton, NJ, Humana Press, pp 319-362
23. Frazer A, Maayani S, Wolfe BB (1990): Subtypes of receptors for serotonin. Annu Rev Pharmacol Toxicol 30:307-348
24. Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983): Identffication of presynar.tic serotonin autoreceptors using a new ligand: 3H-DPAT. Nature 305:140-142
25. Gross-Isseroff R, Biegon A (1988): Autoradiographic analysis of [3H]imipramine binding in the human brain postmortem: effects of age and alcohol. J Neurochem 51: 528-534
26. Gross-Isseroff R, Israeli M, Biegon A (1988): Autoradiographic analysis of [3H]desmethyl-imipramine binding in the human brain postmortem. Brain Res 456:120-126
27. Gross-Isseroff R, Israeli M, Biegon A (1989): Autoradiographs: analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry 46:237-241
28. Gross-Isseroff R, Salama D, Israeli M, Biegon A (1990): Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Res 519:223-227
29. Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985): 3H-8-Hydroxy-2-(di-n-propylamino)-tetralin binding to pre-and post-synaptic 5-hydroxy-tryptamine binding sites in various regions of the rat brain. J Neurochem 44:1685-1696
30. Hashimoto T, Nishino N, Nakai H, Tanka C (1991): Increase in serotonin 5-HTlA receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia. Life Sci 48:355-363
31. Hensler JG, Kovachich GB, Frazer A (1991): A quantitative autoradiographic study of serotoniniA receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144
32. Hoyer D, Pazos A, Probst A, Palacios JM (1986): Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HTic and 5-HT2 recognition sites. Brain Res 376:97-107
33. Hoyer D, Vos P, Closse A, Palacios JM, Engel G, Daveirs H (1987): 3H-ketanserin labels serotonin 5-HT2 and ai-adrenergic receptor in human brain cortex. J Cardiovasc Pharmacol 10 [Suppl 3]: 548-550
34. Iqbal N, Asnis GM, Wetzler S, Kay SR, van Praag HM (1991): The role of serotonin in schizophrenia new findings. Schizophrenia Res 5:181-182
35. MH, Baker HF, Crow TJ, Riley GJ, Rigsby D (1979): Brain tryptophan metabolism in schizophrenia: A postmortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects. Psychopharmacology 62:279-285
36. Joyce JN, Sapp DW, Marshall JF (1986): Human striatal dopamine receptors are organized in compartments. Proc Natl Acad Sci USA 83:8002-8006
37. Joyce JN, Lexow N, Bird E, Winokur A (1988): Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2:546-557
38. Joyce JN, Janowski A, Neve H (1991): Characterization and distribution of [125i]Epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J Phymacol Exp Ther 253:1253-1263
39. Joyce JN, Lexow N, Kim SJ, Artymyshyn R, Cassanova M, Keinman J, Bird E, Winokur A (1992): Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse 10:228-246
40. Korpi ER, Kleinman JE, Goodman SI, Phillips I, DeLisi LE, Linnoila M, Wyatt RJ (1986): Serotonin and 5-hydroxy-indoleacetic acid in the brains of suicide victims: Comparison in chronic schizophrenic patients with suicide as cause of death. Arch Gen Psychiatry 43:594-600
41. Kovachich GB, Aronson CE, Brunswick DJ, Frazer A (1988): Quantitative autoradiography of serotonin uptake sites in rat brain pH]cynaoimipramine. Brain Res 454:78-88
42. Larnelle M, Maloteaux JM (1989): Regional distribution of serotonergic pre-and postsynaptic markers in human brain. Acta Psychiatr Scand Suppl 350:56-59
43. Larnelle M, Casanova F, Weinberger DR, Kleinman JE (1990): [3H]paroxetine binding in postmortem brains of schizophrenic, suicides, cocaine addicts and controls. Soc Neu-rosci Abstr 16:1350
44. Lavoie B, Parent A (1990): Immunohistochemical study of the serotoninergic innovation of the basal ganglia in the squirrel monkey. J Comp Neurol 299:1-16
45. Lawrence De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW (1990): Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res 526:17-22
46. Lav T, Tang SW (1984): Loxapine and clozapine decrease serotonin (52) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res 12:277-285
47. Rysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janseen PAJ (1986): Down regulation of serotonin-52 receptor sites in rat brain by chronic treatment with serotonin-52 antagonists: Ritanserin and setoperone. Psychopharmacology 88:434-444
48. Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PAJ (1987): Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a DOPAC release system on dopaminergic nerve endings. Eur J Pharmacol 134:373-376
49. Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PAJ (1988): Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets: relation with release of biogenic amine metabolites induced by ketanserin-and tetrabenazine-like drugs. J Pharmacol Exp Ther 244: 310-321
50. Lidow MS, Goldman-Rakic PS, Rakic P, Gallagher DW (1988): Differential quenching and limits of resolution in autoradiograms of brain tissue labeled with 3H-, i25l-and i4C-compounds. Brain Res 459:105-119
51. Lidow MS, Goldman-Rakic PS, Gallagher DW, Rakic P (1989): Quantitative autoradiographic mapping of serotonin 5-HTi and 5-HT2 receptors and uptake sites in the neocortex of the rhesus monkey. J Comp Neurol 280:27-42
52. Lowenstein PR, Joyce JN, Coyle JT, Marshall JF (1990): Stri-osomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: A quantitative receptor autoradiographic study. Brain Res 510:122-126
53. Mackay ABP, Doble A, Bird ED, Spokes EG, Ouik M, Iver-sen LL (1978): 3H-Spiperone binding in normal and schizophrenic post-mortem human brain. Life Sci 23: 527-532
54. Mann JJ, Stanley M, McBride PA, McEwen BS (1986): Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Cen Psychiatry 43:954-959
55. McKeith IG, Marshall EG, Ferrier IN, Armstrong MM, Kennedy WN, Perry Perry EK, Eccleston D (1987): 5-HT receptor binding in post-mortem brain from patients with afective disorder. J Affective Dis 13:67-74
56. Meltzer F (1989): Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:518-527
57. Meltzer Matsubara S, Lee J-C (1989): Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonins pKi values. J Pharmacol Exp Ther 251:238-246
58. Mita T, Handa S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C (1986): Decreased serotonin 52 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21:1407-1414
59. Nieuwenhuis R, Voogd J, Van Hijzen C (1978): The Human CentralNervous System. A Synopsis and Atlas. Berlin, Springer
60. O'Dell SJ, La Hoste GJ, Widmark CV, Shapiro Potkin SG, Marshall JE (1990): Chronic treatment with clozapine or haloperidol diferentially regulates dopamine and serotonin receptors in rat brain. Synapse 6:146-153
61. Owen F, Cross AJ, Crow TJ, Lofthouse R, Poulter M (1981): Neurotransmitter receptors in brain in schizophrenia. Acta Psychiatr Scand 63:20-28
62. Pazos A, Probst A, Palacios JM (1987a): Serotonin receptors in the human brain. III. Auto-radiographic mapping of serotonin-l receptors. Neuroscience 21:97-122
63. Pazos A, Probst A, Palacios JM (1987b): Serotonin receptors in the human brain. IV. Auto-radiographic mapping of serotonin-2 receptors. Neuroscience 21:123-139
64. Reynolds GP, Rossor MN, Iversen LL (1983): Preliminary studies of human cortical 5HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transmission 18 (Suppl):273-277
65. Roy A (1984): Attempted suicide in chronic schizophrenia. Br J Psychiatry 144:303-306
66. Schotte A, Maloteaux JM, Laduron PM (1983): Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 276:231-235
67. Snedecor GW, Cochran WG (1967): Statistical Methods. Ames, Iowa, Iowa State University Press
68. Stanley M, Mann JJ (1983): Increased serotonin-2binding sites in frontal cortex of suicide victims. Lancet 1:214-216
69. Stanley M, Virgilio J, Gushon S (1982): Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 18:1337-1339
70. Tork I (1990): Anatomy of the serotonergic system. Ann Acad Sci 600:9-35
71. Vergé D, Daval G, Marcinkiewicz M, Patey A, Mestikawy SE, Gozlan H, Hamon M (1986): Quantitative autoradiography of multiple 5-HTi receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neu-rosci 6:3474-3482.
72. Vinar O, Molcan J, Nahunek K, Svestka J, Zapletalek M (1989): Ritanserin in schizophrenic patients. Activ Nerv Super 31:107-109
73. Whitaker PM, Crow TJ, Ferrier IN (1981): Tritiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38:278-280
74. Wilmot CA, Szczepanik K (1989): Effect ofacute and chrorac treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288-298
75. Wilson Molliver ME (1991): The organization of sera-tonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 44:537-553
76. Winblad B, Bucht G, Gottfries CG, Roos BE (1979): Monoamines and monoamine metabolites in brains from demented schizophrenics. Acta Psychiatr Scand 60:17-28
77. Yates M, Leake A, CandyJM, Fairborn AF, McKeith IG, Ferrier IN (1990): 5HT2 receptor changes in major depression. Biol Psychiatry 27:489-496
78. Zubenko GS, Moossy J, Martinez J, Rao G, Claassen D, Rosen J, Kopp U (1991): Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 48:619-624